rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lesley Russell

Director

Company insider

Files Form 4 as: Director, Enanta Pharmaceuticals; Director, Endocyte; Director, Amag Pharmaceuticals; Chief Medical Officer, Innocoll Holdings; Chief Operating Officer, Tetralogic Pharmaceuticals; Exec VP, Chief Medical Off, Cephalon.

Every Form 4 they filed

In numbers

Trades disclosed
127
Buys
1
Sells
4
Bought
$98K
Sold
$4.8M
Companies
6
Companies where not an officer
3
First trade
1 Dec 2006
Last trade
11 Mar 2026
Last filed
13 Mar 2026

Companies traded

Where they are an officer
Innocoll HoldingsOfficer · last 24 Jul 20170 buys · 0 sells
Tetralogic PharmaceuticalsOfficer · last 28 Jan 20151 buy · 0 sells
CephalonOfficer · last 14 Oct 20110 buys · 4 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ENTA Enanta PharmaceuticalsDirector · Biotechnology · last 11 Mar 20260 buys · 0 sells
EndocyteDirector · last 21 Dec 20180 buys · 0 sells
Amag PharmaceuticalsDirector · last 7 Jun 20180 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Mar 2026filed 13 Mar 2026ENTA Enanta Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
11 Mar 2026filed 13 Mar 2026ENTA Enanta Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
13 Mar 2025filed 14 Mar 2025ENTA Enanta Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—15,700 at $0.00filing
6 Mar 2024filed 8 Mar 2024ENTA Enanta Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—15,700 at $0.00filing
2 Mar 2023filed 6 Mar 2023ENTA Enanta Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—10,800 at $0.00filing
3 Mar 2022filed 7 Mar 2022ENTA Enanta Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
2 Mar 2021filed 4 Mar 2021ENTA Enanta Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
26 Feb 2020filed 28 Feb 2020ENTA Enanta Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
28 Feb 2019filed 1 Mar 2019ENTA Enanta Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
21 Dec 2018filed 21 Dec 2018Endocyteoption or derivativeSEC FORM 4 Code D$402K28,000 at $14.37filing
21 Dec 2018filed 21 Dec 2018Endocyteoption or derivativeSEC FORM 4 Code D$155K14,000 at $11.06filing
21 Dec 2018filed 21 Dec 2018Endocyteoption or derivativeSEC FORM 4 Code D$242K14,000 at $17.31filing
21 Dec 2018filed 21 Dec 2018Endocyteoption or derivativeSEC FORM 4 Code D$243K13,500 at $17.98filing
21 Dec 2018filed 21 Dec 2018Endocyteoption or derivativeSEC FORM 4 Code D$279K13,500 at $20.65filing
21 Dec 2018filed 21 Dec 2018Endocyteoption or derivativeSEC FORM 4 Code D$424K19,500 at $21.73filing
21 Dec 2018filed 21 Dec 2018Endocyteoption or derivativeSEC FORM 4 Code D$257K19,500 at $13.19filing
21 Dec 2018filed 21 Dec 2018EndocyteSEC FORM 4 Code D$187K7,800 at $24.00filing
21 Dec 2018filed 21 Dec 2018EndocyteSEC FORM 4 Code D$79K3,300 at $24.00filing
7 Jun 2018filed 8 Jun 2018Amag Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—7,543 at $0.00filing
7 Jun 2018filed 8 Jun 2018Amag PharmaceuticalsSEC FORM 4 Code A—3,578 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed5

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.